PubMatic (NASDAQ:PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that it has entered into a definitive agreement to acquire Martin, a media measurement and reporting platform, deepening the company’s investment in supply path optimization (SPO).
Why Is Cancer Treatment Focused POINT Biopharma Stock Trading Higher Today?
Eli Lilly And Co (NYSE: LLY) agreed to acquire POINT Biopharma Global Inc (NASDAQ: PNT) at $12.50 per share in cash, an aggregate of